These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 1596900

  • 1. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.
    Yokota T, Milenic DE, Whitlow M, Schlom J.
    Cancer Res; 1992 Jun 15; 52(12):3402-8. PubMed ID: 1596900
    [Abstract] [Full Text] [Related]

  • 2. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
    Yokota T, Milenic DE, Whitlow M, Wood JF, Hubert SL, Schlom J.
    Cancer Res; 1993 Aug 15; 53(16):3776-83. PubMed ID: 8339291
    [Abstract] [Full Text] [Related]

  • 3. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.
    Milenic DE, Yokota T, Filpula DR, Finkelman MA, Dodd SW, Wood JF, Whitlow M, Snoy P, Schlom J.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6363-71. PubMed ID: 1933899
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
    Sharkey RM, Gold DV, Aninipot R, Vagg R, Ballance C, Newman ES, Ostella F, Hansen HJ, Goldenberg DM.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):828s-834s. PubMed ID: 2297729
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
    Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986
    [Abstract] [Full Text] [Related]

  • 8. Combined immunohistochemical and autoradiographic analyses of antigen/antibody interactions in tumor xenograft models.
    DePalatis LR, Johnson KA, Kaplan DA.
    Lab Invest; 1991 Jul 01; 65(1):111-20. PubMed ID: 2072661
    [Abstract] [Full Text] [Related]

  • 9. Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv molecules.
    Schott ME, Milenic DE, Yokota T, Whitlow M, Wood JF, Fordyce WA, Cheng RC, Schlom J.
    Cancer Res; 1992 Nov 15; 52(22):6413-7. PubMed ID: 1423290
    [Abstract] [Full Text] [Related]

  • 10. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ, Khazaeli MB, Mayo MS, Roberson PL.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts.
    Sharkey RM, Motta-Hennessy C, Pawlyk D, Siegel JA, Goldenberg DM.
    Cancer Res; 1990 Apr 15; 50(8):2330-6. PubMed ID: 2180566
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
    Tahtis K, Lee FT, Smyth FE, Power BE, Renner C, Brechbiel MW, Old LJ, Hudson PJ, Scott AM.
    Clin Cancer Res; 2001 Apr 15; 7(4):1061-72. PubMed ID: 11309358
    [Abstract] [Full Text] [Related]

  • 15. Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 IgG and F(ab')2 fragments in ovarian carcinoma patients.
    Buist MR, Kenemans P, den Hollander W, Vermorken JB, Molthoff CJ, Burger CW, Helmerhorst TJ, Baak JP, Roos JC.
    Cancer Res; 1993 Nov 15; 53(22):5413-8. PubMed ID: 8221680
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D, Pavlinkova G, Beresford G, Booth BJ, Choudhury A, Batra SK.
    Q J Nucl Med; 1998 Dec 15; 42(4):225-41. PubMed ID: 9973838
    [Abstract] [Full Text] [Related]

  • 17. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
    Holton OD, Black CD, Parker RJ, Covell DG, Barbet J, Sieber SM, Talley MJ, Weinstein JN.
    J Immunol; 1987 Nov 01; 139(9):3041-9. PubMed ID: 3499463
    [Abstract] [Full Text] [Related]

  • 18. Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.
    Buchegger F, Pfister C, Fournier K, Prevel F, Schreyer M, Carrel S, Mach JP.
    J Clin Invest; 1989 May 01; 83(5):1449-56. PubMed ID: 2708519
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates.
    Schlom J, Eggensperger D, Colcher D, Molinolo A, Houchens D, Miller LS, Hinkle G, Siler K.
    Cancer Res; 1992 Mar 01; 52(5):1067-72. PubMed ID: 1310638
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.